Luteal support with vaginal micronized progesterone gel in assisted reproduction (Q35123418)

6 August 2017

title

Luteal support with vaginal micronized progesterone gel in assisted reproduction (English)

1 reference

6 August 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12735861

31 December 2023

Alan S. Penzias

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12735861

31 December 2023

Michael M. Alper

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12735861

31 December 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12735861

31 December 2023

publication date

1 April 2003

1 reference

full work available at URL

6 August 2017

https://doi.org/10.1016/s1472-6483(10)61847-0

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12735861

https://api.elsevier.com/content/article/PII:S1472648310618470?httpAccept=text/xml

31 December 2023

1 reference

https://api.crossref.org/works/10.1016/S1472-6483(10)61847-0

https://api.elsevier.com/content/article/PII:S1472648310618470?httpAccept=text/plain

31 December 2023

1 reference

https://api.crossref.org/works/10.1016/S1472-6483(10)61847-0

Reproductive BioMedicine Online

31 December 2023

published in

1 reference

6 August 2017

volume

6

1 reference

6 August 2017

issue

3

1 reference

6 August 2017

page(s)

287-295

1 reference

Luteal phase support with 17alpha-hydroxyprogesterone versus unsupported cycles in in vitro fertilization: a comparative randomized study

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961847-0

7 January 2021

Uterine endometrial peristalsis--a transvaginal ultrasound study.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961847-0

7 January 2021

Sedative and hypnotic effects of oral administration of micronized progesterone may be mediated through its metabolites.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961847-0

7 January 2021

Prospective randomized comparison of human chorionic gonadotropin versus intramuscular progesterone for luteal-phase support in assisted reproduction

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961847-0

7 January 2021

The truth is out there: a guide to the pitfalls of interpreting evidence-based medicine in studies of human reproduction

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961847-0

7 January 2021

Early pregnancy loss in in vitro fertilization (IVF) is a positive predictor of subsequent IVF success

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961847-0

7 January 2021

The effect of HCG supplementation after combined GnRH agonist/HMG treatment in an IVF programme

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961847-0

7 January 2021

Effects of natural progesterone on the morphology of the endometrium in patients with primary ovarian failure

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961847-0

7 January 2021

Targeted drug delivery in gynaecology: the first uterine pass effect

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961847-0

7 January 2021

Luteal support after luteinizing hormone-releasing hormone agonist for in vitro fertilization: superiority of human chorionic gonadotropin over oral progesterone

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961847-0

7 January 2021

Use of Crinone vaginal progesterone gel for luteal support in in vitro fertilization cycles

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961847-0

7 January 2021

Transvaginal progesterone: evidence for a new functional 'portal system' flowing from the vagina to the uterus

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961847-0

7 January 2021

Plasma concentrations of progesterone are higher in the uterine artery than in the radial artery after vaginal administration of micronized progesterone in an oil-based solution to postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961847-0

7 January 2021

Direct transport of progesterone from vagina to uterus.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961847-0

7 January 2021

Absorption and preferential vagina-to-uterus distribution after vaginal administration of 99mTc-pertechnetate in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961847-0

7 January 2021

Luteal phase support in in-vitro fertilization using gonadotrophin releasing hormone analogue before ovarian stimulation: a prospective randomized study of human chorionic gonadotrophin versus intramuscular progesterone

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961847-0

7 January 2021

Hormonal control of endometrial receptivity. The egg donation model and controlled ovarian hyperstimulation

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961847-0

7 January 2021

Transvaginal administration of progesterone

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961847-0

7 January 2021

Uterine contractions at the time of embryo transfer alter pregnancy rates after in-vitro fertilization

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961847-0

7 January 2021

Luteal support with micronized progesterone following in-vitro fertilization using a down-regulation protocol with gonadotrophin-releasing hormone agonist: a comparative study between vaginal and oral administration

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961847-0

7 January 2021

Comparison of the efficacy and safety of two formulations of micronized progesterone (Ellios and Utrogestan) used as luteal phase support after in vitro fertilization

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961847-0

7 January 2021

Experience with a novel vaginal progesterone preparation in a donor oocyte program

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961847-0

7 January 2021

Pregnancy rate and ovarian hyperstimulation after luteal human chorionic gonadotropin in in vitro fertilization stimulated with gonadotropin-releasing hormone analog and menotropins

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961847-0

7 January 2021

Crinone 8% (90 mg) given once daily for progesterone replacement therapy in donor egg cycles

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961847-0

7 January 2021

Management and results of sciatic nerve injuries: a 24-year experience

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961847-0

7 January 2021

The luteal phase of cycles utilizing controlled ovarian hyperstimulation and the possible impact of this hyperstimulation on embryo implantation

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961847-0

7 January 2021

Luteal support in IVF using the novel vaginal progesterone gel Crinone 8%: results of an open-label trial in 1184 women from 16 US centers.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961847-0

7 January 2021

Comparison of the pharmacokinetics of crinone 8% administered vaginally versus Prometrium administered orally in postmenopausal women(3).

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961847-0

7 January 2021

Oral versus intramuscular progesterone for in vitro fertilization: a prospective randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961847-0

7 January 2021

Evaluation of an optimal luteal phase support protocol in IVF.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961847-0

7 January 2021

Pharmacokinetics and endometrial tissue levels of progesterone after administration by intramuscular and vaginal routes: a comparative study.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961847-0

7 January 2021

Progesterone alone versus progesterone combined with HCG as luteal support in GnRHa/HMG induced IVF cycles: a randomized clinical trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961847-0

7 January 2021

Profiles of plasma estrogens, progesterone and their metabolites after oral or vaginal administration of estradiol or progesterone

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961847-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961847-0

1 reference

7 January 2021

Luteal support after in-vitro fertilization: Crinone 8%, a sustained release vaginal progesterone gel, versus Utrogestan, an oral micronized progesterone

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961847-0

7 January 2021

Analysis of the bleeding pattern in assisted reproduction cycles with luteal phase supplementation using vaginal micronized progesterone

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961847-0

7 January 2021

Experience with progesterone gel for luteal support in a highly successful IVF programme

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961847-0

7 January 2021

Trial of support treatment with human chorionic gonadotrophin in the luteal phase after treatment with buserelin and human menopausal gonadotrophin in women taking part in an in vitro fertilisation programme

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961847-0

7 January 2021

A prospective randomized study on oestradiol valerate supplementation in addition to intravaginal micronized progesterone in buserelin and HMG induced superovulation

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961847-0

7 January 2021

A prospective randomized comparison of intramuscular or intravaginal natural progesterone as a luteal phase and early pregnancy supplement

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961847-0

7 January 2021

Pituitary gonadotrophin secretory capacity during the luteal phase in superovulation using GnRH-agonists and HMG in a desensitization or flare-up protocol

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961847-0

7 January 2021

The role of luteal phase support in infertility treatment: a meta-analysis of randomized trials

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961847-0

7 January 2021

Comparison between different routes of progesterone administration as luteal phase support in infertility treatments

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961847-0

7 January 2021

Endometrial receptivities after leuprolide suppression and gonadotropin stimulation: histology, steroid receptor concentrations, and implantation rates

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961847-0

7 January 2021

Hormonal monitoring for in-vitro fertilization and related procedures

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2961847-0

7 January 2021

Progesterone administration in patients with absent ovaries

series ordinal

21

1 reference

https://api.crossref.org/works/10.1016/S1472-6483(10)61847-0

A randomized study comparing Crinone 8% and intramuscular progesterone supplementation in in vitro fertilization-embryo transfer cycles

31 December 2023

series ordinal

43

1 reference

https://api.crossref.org/works/10.1016/S1472-6483(10)61847-0

31 December 2023

Identifiers

1 reference

6 August 2017

1 reference